CRP and coronary artery disorder: Compared with CRP, the conventional biomarker of coronary stenosis20, HSPCs is more sensitive in assessing the progression from mild stenosis (<70%) to medium stenosis (≥70%) and reflecting left ventricular end-systolic diameter in CHD patients.